Core Viewpoint - The company has decided to terminate the 2021 Restricted Stock Incentive Plan and cancel the repurchased shares, which will also lead to a reduction in registered capital due to changes in market conditions and the company's operational adjustments [1][3][6]. Group 1: Termination of Incentive Plan - The board of directors and the supervisory board have approved the termination of the 2021 Restricted Stock Incentive Plan and the cancellation of 10,408,656 repurchased shares [1][3]. - The decision to terminate the incentive plan was made after careful consideration, as the original performance targets were deemed unattainable under current market conditions [3][6]. Group 2: Share Repurchase and Capital Reduction - The company has repurchased a total of 10,408,656 shares, which represents approximately 0.79% of the total share capital, with a total expenditure of 34,112,473.58 yuan [2][5]. - Following the cancellation of the repurchased shares, the registered capital will decrease from 1,315,878,571 yuan to 1,305,469,915 yuan [5][6]. Group 3: Compliance and Approval Process - The termination of the incentive plan and the cancellation of shares will require approval from the shareholders' meeting [1][5][7]. - The supervisory board has confirmed that the actions taken are in compliance with relevant laws and regulations, ensuring no adverse impact on the company's operations or shareholder interests [7][8].

Core Points - The company held its 13th meeting of the 10th Supervisory Board on June 27, 2025, to discuss the achievement of conditions for the third release period of the 2021 Restricted Stock Incentive Plan [1] - The meeting approved the release of 37.98075 million shares of restricted stock for 519 incentive targets, confirming that the conditions for the release have been met and are in compliance with relevant laws and regulations [1][2] Summary by Sections Meeting Details - The meeting was conducted via communication methods with 5 supervisors participating in the vote, meeting legal and regulatory requirements [1] Incentive Plan - The 2021 Restricted Stock Incentive Plan's third release period conditions have been achieved, allowing for the legal and valid release of restricted stock for the designated incentive targets [1] - The approval was unanimous with 5 votes in favor and no votes against or abstentions [1]

Core Viewpoint - The company has completed the procedures for the third unlock period of the restricted stock incentive plan, allowing for the circulation of shares that were previously restricted [1][7]. Summary by Sections Incentive Plan Approval and Execution - The company has conducted the necessary approval procedures for the 2021 restricted stock incentive plan, including the review and approval of relevant proposals by the board and the supervisory committee [2][3]. - The initial grant of restricted stock involved 173 individuals, with a total of 1.6477 million shares granted, and the listing date for these shares was December 24, 2021 [2]. Unlocking Conditions and Performance Assessment - The third unlock period for the restricted stock is defined as the period from 42 months after the initial grant registration to the last trading day within 54 months from the grant date, allowing for 40% of the total granted shares to be unlocked [7]. - The company has confirmed that the conditions for unlocking the third period have been met, with 143 individuals eligible to unlock a total of 1,787,948 shares [7][18]. Changes in Share Structure - Following the unlocking of shares, the total number of shares with restrictions decreased from 77,083,531 to 75,295,583, while the total number of unrestricted shares increased from 151,904,648 to 153,692,596 [18]. - The total share capital of the company remains at 228,988,179 shares after the adjustments [18]. Adjustments to the Incentive Plan - The number of individuals participating in the incentive plan has been adjusted due to personal reasons leading to the forfeiture of shares by some participants, resulting in a reduction of the total granted shares [14][15]. - The company has also conducted buybacks of restricted shares from individuals who no longer qualify for the incentive plan due to leaving the company [5][16].

Core Viewpoint - The independent financial advisor report indicates that the conditions for the fourth vesting period of the initial grant and the third vesting period of the reserved grant under the 2021 restricted stock incentive plan of Aibo Medical have been met [1][12]. Summary by Sections Company Overview - Aibo Medical, officially known as Aibo Nord (Beijing) Medical Technology Co., Ltd., is involved in a restricted stock incentive plan aimed at motivating key personnel [1]. Incentive Plan Details - The initial grant's fourth vesting period is defined as the period from the first trading day after 48 months from the grant date to the last trading day within 60 months from the grant date, which is set from June 16, 2021, to June 15, 2026 [8]. - The reserved grant's third vesting period is defined as the period from the first trading day after 36 months from the reserved grant date to the last trading day within 48 months from the reserved grant date, set from March 31, 2025, to March 27, 2026 [11]. Performance Conditions - For the initial grant, the company must achieve an average compound growth rate of adjusted net profit of 35% for the year 2024, with the actual growth rate reported at 44.87%, thus meeting the performance target [10]. - The performance assessment for individual participants is categorized into four levels: Excellent, Good, Qualified, and Unqualified, determining the actual number of shares vested based on company and individual performance [10][11]. Approval Process - The incentive plan underwent several approval stages, including board meetings and shareholder meetings, with necessary independent opinions and verification from the supervisory board [6][7][8]. Independent Advisor's Opinion - The independent financial advisor confirms that the conditions for the vesting of the restricted stock have been fulfilled and that the relevant matters have received the necessary authorizations and approvals [12].

Core Viewpoint - The legal opinion letter from Deheheng Law Firm confirms that Beijing Huafeng Measurement and Control Technology Co., Ltd.'s stock incentive plan has met the necessary conditions for the fourth vesting period and the third reserved grant period, along with adjustments to the grant price and the cancellation of certain restricted stocks [1][8][14]. Group 1: Approval and Authorization of the Incentive Plan - The incentive plan has been approved and authorized through various resolutions, including the draft of the 2021 Restricted Stock Incentive Plan and the assessment management measures [4][5][6]. - Independent directors and the supervisory board have provided opinions confirming that the incentive plan is beneficial for the company's sustainable development and does not harm the interests of shareholders [4][6]. Group 2: Vesting Conditions - The first vesting period for the incentive plan is set from May 27, 2021, to May 26, 2026, with specific conditions that must be met for the vesting to occur [8][11]. - The conditions for vesting include the absence of negative audit opinions on financial reports and compliance with legal regulations regarding profit distribution [8][10]. Group 3: Adjustments to Grant Price - The grant price has been adjusted due to changes in the company's profit distribution plan, with the new adjusted price being 66.65 RMB per share [13][14]. - The adjustment method follows the formula where the new price is calculated based on the previous price minus the dividend per share [13]. Group 4: Cancellation of Restricted Stocks - A total of 18,136 shares of restricted stock have been canceled due to the departure of one incentive object and the voluntary relinquishment of another [14]. - The board and supervisory board have agreed that the cancellation complies with relevant laws and does not harm shareholder interests [14]. Group 5: Information Disclosure Obligations - The company is required to disclose relevant documents related to the vesting, adjustment, and cancellation of stocks within two trading days following the board meetings [14]. - The company will continue to fulfill its legal obligations for information disclosure as the incentive plan progresses [14].

Core Viewpoint - Beijing Shougang Co., Ltd. plans to repurchase and cancel all remaining restricted stocks from the 2021 incentive plan due to unmet performance targets for the fiscal year 2024 and changes in some incentive recipients [13][23]. Group 1: Board and Supervisory Meetings - The 16th meeting of the 8th Board of Directors and the 13th meeting of the Supervisory Board were held on April 25, 2025, to discuss the repurchase of restricted stocks [2][9]. - All directors and supervisors participated in the meetings, and the decisions made were in compliance with legal regulations and company bylaws [3][9]. Group 2: Repurchase Proposal - The Board approved the proposal to repurchase and cancel a total of 19,013,650 shares of restricted stock due to the failure to meet performance assessment criteria for the fiscal year 2024 [5][13]. - The proposal requires approval from the shareholders' meeting [5][10]. Group 3: Reasons for Repurchase - The company did not meet the performance targets set in the incentive plan, with a net asset return rate of 0.4% and a negative growth rate of -27.89% in operating profit compared to 2019 [23]. - Changes in personnel due to organizational reasons affected 24 incentive recipients, leading to the repurchase of 1,432,692 shares [23][24]. - Two individuals left the company for personal reasons, resulting in the repurchase of 57,222 shares [24]. Group 4: Repurchase Details - The repurchase price is set at 3.25 yuan per share, adjusted from the original price due to previous dividend distributions [25]. - The total number of shares to be repurchased is 19,013,650, which will reduce the company's total share capital [27][28]. Group 5: Impact on Company - The repurchase is not expected to have a significant impact on the company's financial status or operational results [29]. - The management team will continue to strive for value creation for shareholders [29]. Group 6: Legal and Compliance - The repurchase has received necessary approvals and complies with relevant regulations [32]. - The company will notify creditors and undertake necessary legal procedures following the shareholders' approval [33].

北京君合（杭州）律师事务所 关于浙江福莱新材料股份有限公司 回购注销部分限制性股票并调整回购价格等相关事项的 法律意见书 二零二五年三月 关于浙江福莱新材料股份有限公司 回购注销部分限制性股票并调整回购价格等相关事项的 法律意见书 致：浙江福莱新材料股份有限公司 北京君合（杭州）律师事务所（以下简称"君合"或"本所"）为具有从事 法律业务资格的律师事务所。本所接受浙江福莱新材料股份有限公司（以下简称 "福莱新材"或"公司"）的委托，担任福莱新材 2021 年限制性股票激励计划 （以下简称"2021 年激励计划"）和 2023 年限制性股票激励计划（以下简称 "2023 年激励计划"，与 2021 年激励计划合称"激励计划"）的专项法律顾问， 就公司 2021 年激励计划之回购注销部分限制性股票及调整回购价格、2023 年激励 计划之回购注销部分限制性股票及调整回购价格、预留授予（第二批次）部分第 一个解除限售期解除限售条件成就并有关事项出具本法律意见书。 本法律意见书根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励 管理办法》（以 ...